Case Studies1 June 1963Cutaneous Manifestations of the Malignant Carcinoid SyndromeSevere Pruritus and Orange BlotchesCHARLES E. MENGEL, M.D.CHARLES E. MENGEL, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-58-6-989 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCutaneous phenomena are the most characteristic and frequently recognized of the various clinical manifestations of the carcinoid syndrome. These occur as spontaneous or induced intermittent phenomena, a variety of colors being described (1-7). In addition, permanent changes with dilatation of capillaries and venules of the skin with a telangiectatic and permanent cyanotic appearance occur late in the course of the disease. These changes may be related in some way to increased circulating serotonin, histamine, or both. The occasional occurrence of pellagrinous cutaneous manifestations in these patients seems to be related to the development of niacin deficiency, secondary to both chronic...References1. BEANFUNK WBD: Vasculocardiac syndrome of metastatic carcinoid. Arch. Intern. Med. (Chicago) 103: 189, 1959. CrossrefGoogle Scholar2. KIERLANDSAUERDEARING RRWGWH: The cutaneous manifestations of the functioning carcinoid. Arch. Derm. (Chicago) 77: 86, 1958. CrossrefGoogle Scholar3. OATESSJOERDSMA JAA: A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Amer. J. Med. 32: 333, 1962. CrossrefMedlineGoogle Scholar4. SJOERDSMAWEISSBACHUDENFRIEND AHS: A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Amer. J. Med. 20: 520, 1956. CrossrefMedlineGoogle Scholar5. SJOERDSMAWEISSBACHTERRYUDENFRIEND AHLLS: Further observation on patients with malignant carcinoid. Amer. J. Med. 23: 5, 1957. CrossrefMedlineGoogle Scholar6. SJOERDSMA A: Serotonin. New Eng. J. Med. 261: 181, 1959. CrossrefMedlineGoogle Scholar7. ZELICKSON AS: Cutaneous manifestations of the carcinoid syndrome. Minnesota Med. 40: 771; passim, 1957. MedlineGoogle Scholar8. UDENFRIENDTITUSWEISSBACH SEH: The identification of 5-hydroxyindoleacetic acid in normal urine and a new method for its assay. J. Biol. Chem. 216, 499, 1955. CrossrefMedlineGoogle Scholar9. WEAVERMETZANLYANRUNDLES WTENWGWR: The use of serotonin antagonists in the treatment of the malignant carcinoid syndrome. Surg. Forum 12: 330, 1961. MedlineGoogle Scholar10. DALGLIESH CE: Isolation and examination of urinary metabolites containing an aromatic ring. J. Clin. Path. 8: 73, 1955. CrossrefMedlineGoogle Scholar11. DALGLIESH CE: Two dimensional paper chromatography of urinary indoles and related substances. Biochemistry 64: 481, 1956. Google Scholar12. MENGELKELLY CEMG: Biochemical and morphologic changes in a mast-cell neoplasm during treatment with cyclophosphamide. Cancer Res. 21: 1545, 1961. MedlineGoogle Scholar13. PRICE JM: The determination of n-methyl-2-pyridone-5-carboxamide in human urine. J. Biol. Chem. 211: 117, 1954. CrossrefMedlineGoogle Scholar14. WEISSBACHWAALKESUDENFRIEND HTPS: A simplified method for measuring serotonin in tissues: simultaneous assay of both histamine and serotonin. J. Biol. Chem. 230: 865, 1958. CrossrefMedlineGoogle Scholar15. SHOREBURKHALTERCOHN PAAVH: A method for the fluorometric assay of histamine in tissues. J. Pharmacol. Exp. Ther. 127: 182, 1959. MedlineGoogle Scholar16. MENGELTRIER CEJS: Biochemical and morphologic heterogeneity in a transplantable mast-cell neoplasm. J. Nat. Cancer Inst. 27: 1341, 1961. MedlineGoogle Scholar17. STEINER K: Cutaneous mast cells in carcinoid. Arch. Derm. (Chicago) 84: 477, 1961. CrossrefGoogle Scholar18. BOWDENBROWNBATTY KBGJE: 5-hydroxytryptamine: its occurrence in cowhage. Nature 174: 925, 1954. CrossrefMedlineGoogle Scholar19. GRAHAMGOODELLWOLFF DTHHG: Studies on pain: the relation between cutaneous vaso dilatation, pain threshold and spontaneous itching and pain. Amer. J. Med. Sci. 234: 420, 1957. CrossrefMedlineGoogle Scholar20. KEELE CA: Chemical causes of pain and itch. Proc. Roy. Soc. Med. 50: 477, 1957. CrossrefMedlineGoogle Scholar21. CARMIAKUZKENDALL FEV: Experimental histamine pruritus. Arch. Derm. (Chicago) 69: 206, 1954. Google Scholar22. BROADBENT JL: Observations in itching produced by cowhage and on the part played by histamine as a mediator of the itch sensation. Brit. J. Pharmacol. 8: 263, 1953. Google Scholar23. PERNOWWALDENSTRÖM BJ: Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and histamine in thirty-three cases of carcinoid tumor (argentaffinoma). Amer. J. Med. 23: 16, 1957. CrossrefMedlineGoogle Scholar24. ARTHURSHELLEY RPWB: The nature of itching in dermatitic skin. Ann. Intern. Med. 49: 900, 1958. LinkGoogle Scholar25. GAILITISSCHEIBER RJW: Malignant carcinoid syndrome and latest concepts in serotonin metabolism, use of cortisone, prednisone and antiserotonin compound, 45-50. Amer. J. Surg. 99: 84, 1960. CrossrefMedlineGoogle Scholar26. URELESMURRAYWOLF ALMR: Results of pharmacologic treatment in the malignant carcinoid syndrome. New Eng. J. Med. 267, 435, 1962. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: CHARLES E. MENGEL, M.D.Affiliations: Durham, North CarolinaDr. Mengel is a Markle Scholar in Academic Medicine.This study was supported by United States Public Health Service grant C-6452.Requests for reprints should be addressed to Charles E. Mengel, M.D., Department of Medicine, Duke University Medical Center, Durham, North Carolina. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAre itch and scratching the nausea and vomiting of skin?Kutane Symptome bei Diabetes mellitus und anderen EndokrinopathienEdèmes par fibröses rétropéritonéale et tricuspidienne avec atteinte cutanée sclérodermiforme révélateurs d'une tumeur carcinoïde. À propos d'une observation et revue de la littératurePruritusThe pulmonary Kulchitsky cell (neuroendocrine) cancers: From carcinoid to small cell carcinomasEndokrine Tumoren des DünndarmsCarcinoid SyndromeUnusual cutaneous associations of a malignant carcinoid tumour of the bronchus—erythema annulare centrifugum and white banding of the toe nailsITCHING: THE PATHOPHYSIOLOGY OF PRURITUSBlood prostaglandin activity associated with noradrenaline-provoked flush in the carcinoid syndromeThe Itching PatientThe carcinoidScratching the Surface of the ItchHautveränderungen bei inneren ErkrankungenThe malignant carcinoid syndromeTherapy of the Malignant Carcinoid SyndromeCHARLES E. MENGEL, M.D.Clinical and biochemical effects of cyclophosphamide in patients with malignant carcinoid 1 June 1963Volume 58, Issue 6Page: 989-993KeywordsAcademic medicineCapillariesCatheterizationExcretionHistamineMedical servicesNiacinSerotoninStenosisVenules ePublished: 1 December 2008 Issue Published: 1 June 1963 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Charles E. Mengel (1963) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: